Dr. Haris Zahoor, MD, MS

Claim this profile

Cancer Partners of Nebraska

Studies Transitional Cell Carcinoma
Studies Bladder Cancer
2 reported clinical trials
6 drugs studied

Area of expertise

1

Transitional Cell Carcinoma

Haris Zahoor, MD, MS has run 1 trial for Transitional Cell Carcinoma. Some of their research focus areas include:

Stage IV
HER2 positive
Stage III
2

Bladder Cancer

Haris Zahoor, MD, MS has run 1 trial for Bladder Cancer. Some of their research focus areas include:

Stage IV
HER2 positive
Stage III

Affiliated Hospitals

Image of trial facility.

Cancer Partners Of Nebraska

Clinical Trials Haris Zahoor, MD, MS is currently running

More about Haris Zahoor, MD, MS

Clinical Trial Related

2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Haris Zahoor, MD, MS has experience with

  • Carboplatin
  • Cisplatin
  • Disitamab Vedotin
  • Gemcitabine
  • Pembrolizumab
  • NovoTTF-200T

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Haris Zahoor, MD, MS specialize in?

Is Haris Zahoor, MD, MS currently recruiting for clinical trials?

Are there any treatments that Haris Zahoor, MD, MS has studied deeply?

What is the best way to schedule an appointment with Haris Zahoor, MD, MS?

What is the office address of Haris Zahoor, MD, MS?

Is there any support for travel costs?